The trade that takes risk off bank balance sheets
Capital relief only works if the protection seller can pay when the loans go bad, and nobody outside the deal knows who that is or how they are funded.
AIB Group is working with Banco Santander and the insurance broker Howden on a significant risk transfer covering about €2.5bn ($2.9bn) of project finance loans, due to complete later this year, Bloomberg reports. Sales of SRTs are on course for a record $45bn in 2026, up from $41bn in 2025, on Crescent Capital's estimates. The mechanics matter. In an SRT the bank keeps the loans. It buys protection on the first slice of losses from outside investors, who are paid coupons that Bloomberg describes as reaching double digits. The bank's regulatory capital requirement falls — AIB told investors in July that this deal should be worth 25 to 30 basis points of core tier 1 — and that freed capital can be lent again or paid out to shareholders. So the loan is still measured, still supervised, still on a published balance sheet. The loss is not. It sits with whoever sold the protection, in a fund or an insurance wrapper that marks its own book and discloses on its own schedule. The presence of an insurance broker on the deal suggests part of the protection is insurance-structured rather than a cash-collateralised note, though the report does not say, and it does not name the buyers. This is Crash Lab's thesis in its purest form: not a hidden loan, but a hidden loss position, growing at roughly 10% a year in a market that only began publishing size estimates recently. AIB's first SRT was in November 2024. Its third is nearly twice the size of its first.